Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 638,922
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $60,375,372
Total People Sold 5 5 6 8
Total Sell Transactions 11 15 24 57
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1355
  Page 3 of 55  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mueller Brian VP, Corporate Controller   •       –      –    2014-12-02 4 OE $28.23 $141,150 D/D 5,000 9,593     -
   Mueller Brian VP, Corporate Controller   •       –      –    2014-12-01 4 S $90.25 $627,238 D/D (6,950) 4,593     -
   Mueller Brian VP, Corporate Controller   •       –      –    2014-12-01 4 OE $14.39 $145,785 D/D 6,950 11,543     -
   Mueller Brian VP, Corporate Controller   •       –      –    2014-11-26 4 S $88.97 $302,508 D/D (3,400) 4,593     -
   Davis George Eric SVP, General Counsel   •       –      –    2014-11-25 4 AS $89.75 $1,795,000 D/D (20,000) 64,426     -
   Davis George Eric SVP, General Counsel   •       –      –    2014-11-25 4 OE $26.49 $529,800 D/D 20,000 84,426     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-11-25 4 AS $90.00 $180,000 I/I (2,000) 43,195     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-11-25 4 OE $12.99 $25,980 I/I 2,000 45,195     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-11-13 5 GD $0.00 $0 D/D 2,400 230,768     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-11-12 4 S $81.51 $81,513 D/D (1,000) 228,157     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2014-11-10 4 S $86.55 $1,730,982 D/D (20,000) 76,550     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2014-11-10 4 OE $21.51 $430,200 D/D 20,000 96,550     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-11-10 4 S $87.00 $348,000 I/I (4,000) 43,195     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-11-10 4 OE $12.99 $51,960 I/I 4,000 47,195     -
   Baffi Robert EVP, Technical Operations   •       –      –    2014-11-05 5 GA $0.00 $0 I/I 46 23,935     -
   Baffi Robert EVP, Technical Operations   •       –      –    2014-11-05 5 GD $0.00 $0 D/D 46 99,200     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-11-03 4 S $85.33 $256,002 I/I (3,000) 43,195     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2014-11-03 4 AS $83.54 $3,926 D/D (47) 31,590     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2014-10-31 4 A $31.26 $1,469 D/D 47 31,637     -
   Davis George Eric SVP, General Counsel   •       –      –    2014-10-30 4 S $83.20 $1,247,930 D/D (15,000) 64,426     -
   Davis George Eric SVP, General Counsel   •       –      –    2014-10-30 4 OE $26.49 $397,350 D/D 15,000 79,426     -
   Baffi Robert EVP, Technical Operations   •       –      –    2014-10-30 4 S $81.70 $2,447,959 D/D (29,963) 99,200     -
   Baffi Robert EVP, Technical Operations   •       –      –    2014-10-30 4 OE $38.59 $1,156,272 D/D 29,963 129,163     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-10-29 5 GA $0.00 $0 D/D 7,011 233,168     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2014-10-29 5 GD $0.00 $0 I/I 7,011 36,184     -
  1355 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 55
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us